These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20351870)

  • 41. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Klein TE; Altman RB
    Pharmacogenomics J; 2004; 4(1):1. PubMed ID: 14735107
    [No Abstract]   [Full Text] [Related]  

  • 42. A Web-Based Pharmacogenomics Search Tool for Precision Medicine in Perioperative Care.
    Zarei S; Costas Y; Orozco G; Zaydlin M; Mirtar A; Abouali M; Diaz-Marty C; Akhlaghipour G; Fernandez Altamirano P; Gonzalez Cardona AR; Reiley LE; Mirzakhani H
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32708157
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.
    McConnell H; Andrews TD; Field MA
    PeerJ; 2021; 9():e11774. PubMed ID: 34316407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison.
    Monnin P; Legrand J; Husson G; Ringot P; Tchechmedjiev A; Jonquet C; Napoli A; Coulet A
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):139. PubMed ID: 30999867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expectations, validity, and reality in pharmacogenetics.
    Limdi NA; Veenstra DL
    J Clin Epidemiol; 2010 Sep; 63(9):960-9. PubMed ID: 19995676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic ancestry plays a central role in population pharmacogenomics.
    Yang HC; Chen CW; Lin YT; Chu SK
    Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine.
    Zhao Y; Brush M; Wang C; Wagner AH; Liu H; Freimuth RR
    Bioinformatics; 2022 Nov; 38(23):5279-5287. PubMed ID: 36222570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-Specific Analysis of Pharmacological Pathways.
    Hao Y; Quinnies K; Realubit R; Karan C; Tatonetti NP
    CPT Pharmacometrics Syst Pharmacol; 2018 Jul; 7(7):453-463. PubMed ID: 29920991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disambiguation of PharmGKB drug-disease relations with NDF-RT and SPL.
    Zhu Q; Freimuth RR; Pathak J; Durski MJ; Chute CG
    J Biomed Inform; 2013 Aug; 46(4):690-6. PubMed ID: 23727027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
    Fan M; Bousman CA
    Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin pharmacogenomics: current best evidence.
    Kimmel SE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S266-71. PubMed ID: 26149035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML.
    Rubin DL; Hewett M; Oliver DE; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():88-99. PubMed ID: 11928521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Addressing the challenges of the clinical application of pharmacogenetic testing.
    Ikediobi ON; Shin J; Nussbaum RL; Phillips KA; ; Walsh JM; Ladabaum U; Marshall D
    Clin Pharmacol Ther; 2009 Jul; 86(1):28-31. PubMed ID: 19536122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.
    Mlakar V; Huezo-Diaz Curtis P; Satyanarayana Uppugunduri CR; Krajinovic M; Ansari M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PharmGKB very important pharmacogene: SLCO1B1.
    Oshiro C; Mangravite L; Klein T; Altman R
    Pharmacogenet Genomics; 2010 Mar; 20(3):211-6. PubMed ID: 19952871
    [No Abstract]   [Full Text] [Related]  

  • 60. Antidepressant pharmacogenetics in children and young adults: A systematic review.
    Maruf AA; Greenslade A; Arnold PD; Bousman C
    J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.